Abstract
Objectives This study aims to pilot a community pharmacy chronic obstructive pulmonary disease (COPD) case finding service in England, estimating costs and effects. Methods Patients potentially at risk of COPD were screened with validated tools. Smoking cessation was offered to all smokers identified as potentially having undiagnosed COPD. Cost and effects of the service were estimated. Key findings Twenty-one community pharmacies screened 238 patients over 9 months. One hundred thirty-five patients were identified with potentially undiagnosed COPD; 88 were smokers. Smoking cessation initiation provided a project gain of 38.62 life years, 19.92 quality-adjusted life years and a cost saving of £392.67 per patient screened. Conclusions COPD case finding by community pharmacists potentially provides cost-savings and improves quality of life.
| Original language | English |
|---|---|
| Pages (from-to) | 83-85 |
| Number of pages | 3 |
| Journal | International Journal of Pharmacy Practice |
| Volume | 23 |
| Issue number | 1 |
| DOIs | |
| Publication status | Published - 1 Feb 2015 |
| Externally published | Yes |
Bibliographical note
Publisher Copyright:© 2014 The Authors. International Journal of Pharmacy Practice published by John Wiley & Sons Ltd on behalf of Royal Pharmaceutical Society.
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- COPD
- community pharmacy
- cost-effectiveness
- health promotion
- pharmaceutical public health
Fingerprint
Dive into the research topics of 'Chronic obstructive pulmonary disease case finding by community pharmacists: A potential cost-effective public health intervention'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver